Abstract | OBJECTIVE: METHODS: RESULTS: CONCLUSIONS:
|
Authors | H H Clarice Yang, Jong Moo Kim, Elliott Chum, Cornelis van Breemen, Ada W Y Chung |
Journal | The Journal of thoracic and cardiovascular surgery
(J Thorac Cardiovasc Surg)
Vol. 140
Issue 2
Pg. 305-312.e2
(Aug 2010)
ISSN: 1097-685X [Electronic] United States |
PMID | 20189193
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2010 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved. |
Chemical References |
- Angiotensin II Type 1 Receptor Blockers
- Fbn1 protein, mouse
- Fibrillin-1
- Fibrillins
- Microfilament Proteins
- Protease Inhibitors
- Smad2 Protein
- Smad2 protein, mouse
- Transforming Growth Factor beta
- Matrix Metalloproteinase 2
- Mmp2 protein, mouse
- Matrix Metalloproteinase 9
- Mmp9 protein, mouse
- Losartan
- Doxycycline
|
Topics |
- Angiotensin II Type 1 Receptor Blockers
(administration & dosage)
- Animals
- Aorta, Thoracic
(drug effects, metabolism, pathology, physiopathology)
- Aortic Aneurysm, Thoracic
(drug therapy, genetics, pathology, physiopathology, prevention & control)
- Disease Models, Animal
- Doxycycline
(administration & dosage)
- Drug Synergism
- Drug Therapy, Combination
- Elastic Tissue
(pathology)
- Fibrillin-1
- Fibrillins
- Losartan
(administration & dosage)
- Marfan Syndrome
(complications, drug therapy, genetics, pathology, physiopathology)
- Matrix Metalloproteinase 2
(metabolism)
- Matrix Metalloproteinase 9
(metabolism)
- Mice
- Mice, Inbred C57BL
- Mice, Mutant Strains
- Microfilament Proteins
(genetics)
- Phosphorylation
- Protease Inhibitors
(administration & dosage)
- Secondary Prevention
(methods)
- Smad2 Protein
(metabolism)
- Time Factors
- Transforming Growth Factor beta
(metabolism)
- Vasoconstriction
(drug effects)
- Vasodilation
(drug effects)
|